Fig. 1From: A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancerKaplan-Meier survival analysis according to time to treatment failure (log-rank p = 0.542)Back to article page